Anavex Life Sciences Corp. announced that Kristina M. Capiak, CCRP has been promoted the company's Vice President of Regulatory Affairs. She is overseeing U.S. and international regulatory matters for Anavex, including filings and interactions with the FDA and other regulatory authorities.

Capiak will oversee the Company's clinical development programs and other indications. Ms. Capiak has more than 10 years of academic clinical research and healthcare industry experience within the biotech industry. Prior to joining Anavex, Ms. Capiak was the Global Regulatory Lead at Retrophin Inc. Ms. Capiak's background also includes clinical trial staffing and oversight for more than 60 clinical trials at both Columbia University Medical Center, where she co-authored several papers, and Memorial Sloan-Kettering Cancer Center, where she became a Certified Clinical Research Professional (CCRP) through the Society of Clinical Research Associates.